Checkpoint Therapeutics Inc
General ticker "CKPT" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $169.4M
Checkpoint Therapeutics Inc follows the US Stock Market performance with the rate: 47.7%.
Estimated limits based on current volatility of 8.2%: low 3.27$, high 3.86$
Factors to consider:
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [1.43$, 4.16$]
- 2024-12-30 to 2025-12-30 estimated range: [1.82$, 4.81$]
Financial Metrics affecting the CKPT estimates:
- Negative: Non-GAAP EPS, $ of -3.33 <= 0.10
- Negative: Operating profit margin, % of -99.80 <= 1.03
- Negative: Operating cash flow per share per price, % of -49.02 <= 2.35
- Negative: negative Net income
- Positive: Inventory ratio change, % of 0 <= 0
Short-term CKPT quotes
Long-term CKPT plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.27MM | $0.19MM | $0.10MM |
| Operating Expenses | $56.99MM | $58.52MM | $52.25MM |
| Operating Income | $-56.72MM | $-58.33MM | $-52.15MM |
| Non-Operating Income | $0.05MM | $-4.29MM | $0.30MM |
| Interest Expense | $0.00MM | $4.29MM | $0.00MM |
| R&D Expense | $48.45MM | $49.83MM | $43.57MM |
| Income(Loss) | $-56.67MM | $-62.62MM | $-51.85MM |
| Taxes | $0.00MM | $4.29MM | $0.00MM |
| Profit(Loss) | $-56.67MM | $-66.92MM | $-51.85MM |
| Stockholders Equity | $29.75MM | $-19.48MM | $-13.05MM |
| Inventory | $0.00MM | $0.00MM | $0.00MM |
| Assets | $55.73MM | $13.29MM | $5.38MM |
| Operating Cash Flow | $-26.31MM | $-57.55MM | $-47.59MM |
| Financing Cash Flow | $40.27MM | $14.89MM | $40.45MM |
| Earnings Per Share* | $-7.45 | $-7.57 | $-2.77 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.